Geneo
Geneo manufactures and sells the Glo2Facial multi-technology skin treatment platform (Oxfoliation, RF Pro, ultrasound, detox massage) to a global network of dermatologists, spas, and skincare professionals, who deliver treatments to end consumers via the company's provider locator.
- Company typePrivate
- Founded2014
- HeadquartersWestfield, United States
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
What Geneo does
Geneo is a US-based manufacturer of aesthetic skin treatment equipment operating primarily under the Glo2Facial brand, founded in 2014 and headquartered in Westfield with 51-100 employees. The company builds a proprietary multi-modality treatment platform that combines four physical technologies in a single session: Oxfoliation™ (exfoliation plus topical oxygenation using customized OxyPods), RF Pro by Geneo™ (professional-grade radio frequency for collagen stimulation), lite ultrasound waves (to enhance serum adsorption), and hands-free detox massage (to increase circulation and reduce puffiness). The platform is positioned for both facial and full-body use cases including back acne, bikini-area concerns, keratosis pilaris, and stretch marks, and is sold as safe for all skin types with no downtime.
The company monetizes through a dual-channel B2B-plus-DTC model. Revenue is generated primarily by selling proprietary treatment devices and recurring consumables (OxyPods, serums) to a global network of professional providers — dermatologists, med-spas, and licensed skincare practitioners — recruited via a 'Become a Provider' program and supplied through a dedicated B2B e-commerce storefront at shop.geneo-us.com. A consumer-facing website and a Provider Locator tool drive consumer awareness and route demand to those providers, while organic social (Instagram, Facebook, TikTok), a content blog, earned media (Cosmopolitan Fall 2024, ELLE, Vogue, PopSugar, Byrdie), and industry events support top-of-funnel acquisition. The company is privately held, discloses no funding history, management team, or revenue, and has no disclosed parent, investors, or M&A activity.
Geneo firmographics
Firmographics- Name
- Geneo
- Legal name
- Geneo
- Website
- https://geneo-us.com
- Company type
- Private
- Founded year
- 2014
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Geneo manufactures and sells the Glo2Facial multi-technology skin treatment platform (Oxfoliation, RF Pro, ultrasound, detox massage) to a global network of dermatologists, spas, and skincare professionals, who deliver treatments to end consumers via the company's provider locator.
- Ownership category
- akta.pro rank
Where Geneo is headquartered
LocationHeadquarters
- HQ city
- Westfield
- HQ country
- United States
- HQ region
- North America
Markets served
Geneo business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Technology or R&D, Marketing or Sales, Operations, Personnel
Revenue model
- Treatment Device and Consumables Sales: Glo2Facial generates revenue through the sale of their proprietary treatment devices and consumable OxyPods to professional providers including dermatologists, spas, and skincare clinics. The platform enables providers to offer facial and body treatments to end consumers.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels6 records
Geneo product offering
Product offeringCore offering
Geneo manufactures and distributes the Glo2Facial aesthetic treatment platform, a proprietary multi-technology device that combines Oxfoliation, RF Pro radio frequency, ultrasound, and detox massage into a single session. The company sells the devices and consumable OxyPods to professional providers including dermatologists, spas, and skincare clinics, while also operating a B2B provider shop and consumer-facing website with a Provider Locator to drive demand.
Product overview
Glo2Facial is a single unified skincare treatment platform that combines multiple proprietary technologies in a single session: Oxfoliation (oxygenation and exfoliation), RF Pro (radio frequency for collagen boosting), Ultrasound (serum adsorption enhancement), and Detox (circulation massage). The treatment is designed for use on face and body areas and can be customized with different OxyPods and serums for various skin concerns.
Differentiator
Problem solved
Functional benefit
Brands
- RF Pro by Geneo: Safe and professional-grade radio frequency technology that boosts collagen production and reduces the appearance of fine lines and wrinkles.
- Oxfoliation
Products and services
- Glo2Facial Treatment Platform
Companies that use Geneo
Customer profileSegments3 records
Ideal customer profiles2 records
Geneo technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Geneo partnerships and signals
Strategic signalScale indicators1 record
Recent moves5 records
Expansion highlights5 records
Geneo competitors and assessment
Company assessmentBroad incumbents
- Alma Lasers: Alma is a global manufacturer of professional aesthetic devices (Accent, Soprano, Harmony) sold through dermatology and medspa channels, competing with Glo2Facial across multiple energy-based modalities.
- Cutera: Cutera manufactures professional aesthetic devices (Secret RF, AviClear, truSculpt) for dermatologists and medspas, competing with Glo2Facial in RF-based skin rejuvenation with a larger sales organization and longer operating history.
- Lumenis (Boston Scientific): Lumenis manufactures professional energy-based aesthetic devices including RF and ultrasound platforms (Legend Pro+, NuEra) used in dermatology practices—the same provider channel Glo2Facial targets.
- Sciton: Sciton manufactures professional aesthetic and surgical laser/RF platforms (BBL, Halo, Profractional) sold through dermatologists and plastic surgeons, competing in the same provider channel with a broader technology portfolio.
- Cynosure (Clayton, Dubilier & Rice): Cynosure offers a broad portfolio of professional aesthetic and energy-based devices (TempSure, Potenza, PicoSure) sold through the same provider channel as Glo2Facial, with deeper R&D resources and global reach.
- Solta Medical (Bausch Health): Solta owns Thermage, Clear+Brilliant, and Fraxel—established RF and energy-based aesthetic devices sold through dermatologists. Competes with Glo2Facial's RF Pro technology from a larger incumbent position with global distribution.
Direct peers
- BTL Aesthetics: BTL manufactures professional aesthetic devices (EMFACE, EMSCULPT, Exion) sold through the same dermatologist/medspa channel as Glo2Facial, with proprietary energy-based technology stacks and consumable-driven economics.
- HydraFacial (Edge Systems): HydraFacial is the dominant professional hydradermabrasion device platform sold through dermatologists, spas, and medspas with a recurring consumables model—the closest direct analogue to Glo2Facial's provider + OxyPod architecture.
Emerging players
- Aerolase: Aerolase manufactures portable professional aesthetic laser devices (Neo Elite) for dermatology practices. Comparable in scale to Geneo and competes in the same provider channel with energy-based skin rejuvenation technology.
Others
- Senté Labs: Senté develops professional-grade skincare serums and is an adjacency to Geneo's consumables (OxyPod) business—Senté products are sold through the same dermatology channel and could partner or compete in the in-treatment serum layer.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks6 records
Key highlights6 records
Customer concentration
Geneo social profiles
Digital presenceGeneo financial estimates
Financial estimateRevenue estimate
Valuation estimate
Geneo leadership team
Management profileNumber of profiles
Geneo funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Geneo M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Geneo
What does Geneo do?
Geneo manufactures and distributes the Glo2Facial aesthetic treatment platform, a proprietary multi-technology device that combines Oxfoliation, RF Pro radio frequency, ultrasound, and detox massage into a single session. The company sells the devices and consumable OxyPods to professional providers including dermatologists, spas, and skincare clinics, while also operating a B2B provider shop and consumer-facing website with a Provider Locator to drive demand.
Is Geneo a public or private company?
Geneo is a private company. It is classified as unknown and is currently operating.
When was Geneo founded?
Geneo was founded in 2014. It employs 51 to 100 people.
Where is Geneo based?
Geneo is headquartered in Westfield, United States, in the North America region.
How does Geneo make money?
One revenue line is on record: treatment Device and Consumables Sales.
Who are Geneo's main competitors?
Broad incumbents on record are Alma Lasers, Cutera, Lumenis (Boston Scientific), Sciton, Cynosure (Clayton, Dubilier & Rice) and Solta Medical (Bausch Health). Direct peers are BTL Aesthetics and HydraFacial (Edge Systems). Aerolase is listed as an emerging player. Senté Labs is listed as an others.
Does Geneo have an API?
No public API is recorded for Geneo.